Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
1.470
-0.050 (-3.29%)
At close: Mar 27, 2026, 4:00 PM EDT
1.450
-0.020 (-1.36%)
After-hours: Mar 27, 2026, 4:59 PM EDT

Arcadia Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.264.246.5220.6428.69
Short-Term Investments
4.3-5.12--
Cash & Short-Term Investments
4.564.2411.6420.6428.69
Cash Growth
7.57%-63.56%-43.61%-28.03%11.76%
Accounts Receivable
0.431.180.511.221.37
Inventory
1.210.90.842.324.43
Other Current Assets
0.162.921.991.210.9
Total Current Assets
6.369.2414.9725.435.39
Net Property, Plant & Equipment
0.010.180.862.535.37
Other Intangible Assets
0.040.040.040.040.48
Other Long-Term Assets
0.144.063.830.962.67
Total Assets
6.5513.5219.7128.9243.92
Accounts Payable
1.792.111.912.863.64
Current Portion of Leases
-0.160.851.011.07
Other Current Liabilities
0.270.30.830.340.33
Total Current Liabilities
2.062.563.594.215.04
Long-Term Leases
--0.161.012.22
Other Long-Term Liabilities
0.354.733.262.815.46
Total Long-Term Liabilities
0.354.733.413.817.68
Total Liabilities
2.417.2978.0212.72
Common Stock
0.070.070.070.070.06
Additional Paid-in Capital
285.29285.04284.52278.83257.52
Accumulated Other Comprehensive Income
--0.1--
Retained Earnings
-281.22-278.88-271.84-257.86-226.49
Total Common Shareholders' Equity
4.146.2212.8421.0331.09
Minority Interest
---0.14-0.130.1
Shareholders' Equity
4.146.2212.720.931.2
Total Liabilities & Equity
6.5513.5219.7128.9243.92
Total Debt
00.161.012.023.29
Net Cash (Debt)
4.564.0910.6418.6325.39
Net Cash Growth
11.65%-61.57%-42.91%-26.64%55.63%
Net Cash Per Share
3.333.008.6031.0847.73
Book Value
4.146.2212.8421.0331.09
Book Value Per Share
3.034.5610.3835.0958.44
Tangible Book Value
4.16.1812.820.9930.61
Tangible Book Value Per Share
3.004.5410.3535.0257.53
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q